| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_870c6e68c09f6b820fc9b7fefe1a56fc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-6439 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0654
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-6428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6881 |
| filingDate |
2019-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3753c4811897902d58b79754247411eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_885a8a8cac26e695c8128bc2704c3cfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc991ba34397a5f92aefb8e6ff5d56aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4614f85b5f185d2ebf0e578b0b9d259
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05b2cdcc521d85844fe9115722433b12 |
| publicationDate |
2021-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3856932-A1 |
| titleOfInvention |
Methods and uses for determining osteogenic potential of in vitro differentiated cells |
| abstract |
The application provides the use of CD73, CD105, CD44 and/or CD10 for determining osteogenic potential of in vitro differentiated cells. The application further provides a method for determining osteogenic potential of in vitro differentiated cells comprising measuring the quantity of the in vitro differentiated cells expressing CD73, CD105, CD10 and/or CD44, and/or measuring the quantity of CD73, CD105 and/or CD44 expressed by the in vitro differentiated cells. The invention also provides a method for selecting a subject for preparing in vitro differentiated cells of chondro-osteoblastic lineage comprising recovering MSC from a biological sample of a subject; obtaining in vitro differentiated cells from the MSC; determining the osteogenic potential of the in vitro differentiated cells by a method as disclosed herein; and selecting the subject for preparing in vitro differentiated cells of chondro-osteoblastic lineage if the in vitro differentiated cells have clinically useful osteogenic potential. |
| priorityDate |
2018-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |